tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Nuchev Limited Announces 2025 Annual General Meeting

Story Highlights
Nuchev Limited Announces 2025 Annual General Meeting

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Nuchev Pty Ltd ( (AU:NUC) ) has shared an announcement.

Nuchev Limited has announced the notice of its 2025 Annual General Meeting, which will be held virtually on November 28, 2025. This meeting is significant for shareholders as it affects their shareholding and voting rights. The company continues to emphasize its commitment to providing high-quality nutritional and wellness products, reflecting its strategic positioning in the industry.

The most recent analyst rating on (AU:NUC) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

More about Nuchev Pty Ltd

Nuchev is an Australian-based nutritional and wellness company offering products under brands like Oli6®, Bio Practica, and Medicine Tree. The company distributes globally recognized European brands in Australia and New Zealand, primarily to practitioners as prescription-only products. Oli6® is available in Australian pharmacies, grocery channels, and online in China and Vietnam. Nuchev also distributes Brauer, Skin Physics, and Rapid products in Australia, focusing on sourcing high-quality ingredients and utilizing leading Australian manufacturing facilities.

Average Trading Volume: 19,661

Technical Sentiment Signal: Sell

Current Market Cap: A$21.78M

See more data about NUC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1